使用本网站需要启用 JavaScript, 请启用后刷新页面获得更好的体验
登录
注册
首页
个人基因检测
临床应用研究
科研合作项目
合作与服务
社区
研究所
微解读
应用
姓氏祖源
基因关系
原始数据
纯合片段
使用 WeGene 需要启用 Cookies, 请启用后刷新页面获得更好的体验
社区首页
小组
2型糖尿病
2型糖尿病
发起讨论
2型糖尿病
28 个讨论
只看精华帖
按热门排序
按最新排序
我的十万有99999是怎么回事
ccdebeiai
• 最后回复
z6630162
•
2017-10-24 09:52
3493
7
• 来自相关小组
我血糖耐受受损，餐前约6.8，餐后约10，糖化约6.4，己经用药2年了，糖尿病风险竟然才0.34，是不是吃药引起误差?
luoguoan
• 2017-08-29 17:25
3077
0
• 来自相关小组
二型糖尿病4.16倍
行走的3号染色体
• 2017-08-26 00:29
2457
0
• 来自相关小组
2型糖尿病8.44倍…
小只的6号染色体
• 最后回复
nnlory
•
2017-08-22 18:27
3037
2
• 来自相关小组
如果携带2型糖尿病的基因，还需要了解哪些相关基因问题会更加有帮助？
WendySugus
• 最后回复
yaoxt
•
2017-07-25 15:57
3816
3
• 来自相关小组
没有家族糖尿病史为何糖尿病风险高
豁达的IMPG1基因
• 最后回复
卖萌的GBA3基因
•
2017-07-18 17:15
3895
6
• 来自相关小组
是否可以有二型糖尿病的基因数据呢
朱屹
• 最后回复
朱屹
•
2017-03-21 10:59
3086
2
• 来自相关小组
报告更新后，感觉整个人都不好了
粗眉的SNX29基因
• 最后回复
费力科思
•
2016-12-20 05:26
3772
1
• 来自相关小组
发起讨论
2型糖尿病
28 个讨论
相关基因
WFS1
位点：RS10012946
NRXN3
位点：RS10146997
TMEM258
位点：RS102275
SUGP1
位点：RS10401969
SDHAF4
位点：RS1048886
RNF6
位点：RS10507349
MTNR1B
位点：RS10830963
GRK5
位点：RS10886471
NOTCH2
位点：RS10923931
CHUK
位点：RS11591741
FTO
位点：RS11642841
位点：RS8050136
位点：RS9939609
ADCY5
位点：RS11708067
SLC16A11
位点：RS117767867
GPSM1
位点：RS11787792
TCF7L2
位点：RS12255372
位点：RS4506565
位点：RS7903146
BCL2
位点：RS12454712
ZMIZ1
位点：RS12571751
SLC30A8
位点：RS13266634
位点：RS3802177
IGF2BP2
位点：RS1470579
位点：RS4402960
RPSAP52
位点：RS1531343
KCNK16
位点：RS1535500
ARAP1
位点：RS1552224
TOMM40
位点：RS157582
ST6GAL1
位点：RS16861329
DGKB
位点：RS17168486
PTPRD
位点：RS17584499
GCK
位点：RS1799884
PPARG
位点：RS1801282
VPS26A
位点：RS1802295
AP3S2
位点：RS2028299
TFAP2B
位点：RS2206277
KCNQ1
位点：RS2237892
位点：RS2237895
位点：RS2237897
TRIB3
位点：RS2295490
MRAS
位点：RS2306374
POC5
位点：RS2307111
KCNQ1OT1
位点：RS231362
CMIP
位点：RS2925979
TEX14
位点：RS302864
POU5F1
位点：RS3130501
LPL
位点：RS328
PROX1-AS1
位点：RS340874
DYRK1B
位点：RS367643250
PEPD
位点：RS3786897
位点：RS10425678
MTTP
位点：RS3816873
SRR
位点：RS391300
ZBED3-AS1
位点：RS4457053
ADAMTS9-AS2
位点：RS4607103
CDKAL1
位点：RS4712523
位点：RS7756992
位点：RS9465871
HNF4A
位点：RS4812829
ANK1
位点：RS516946
KCNJ11
位点：RS5219
MAEA
位点：RS6815464
ARL15
位点：RS702634
GLIS3
位点：RS7041847
HMG20A
位点：RS7178572
PNPLA3
位点：RS738409
RASGRP1
位点：RS7403531
HNF1B
位点：RS757210
位点：RS11651052
CEP68
位点：RS7572857
THADA
位点：RS7578597
RBMS1
位点：RS7593730
GCKR
位点：RS780094
PRC1-AS1
位点：RS8042680
位点：RS2290203
JAZF1
位点：RS864745
TP53INP1
位点：RS896854
ZFAND3
位点：RS9470794
SGCG
位点：RS9552911
MACF1
位点：RS2296172
KIF9
位点：RS2276853
ACSL1
位点：RS60780116
JADE2
位点：RS329122
SSR1
位点：RS9505118
UBE3C
位点：RS1182436
位点：RS1182389
BRAF
位点：RS9648716
PLEKHA1
位点：RS2292626
HSD17B12
位点：RS1061810
WSCD2
位点：RS3764002
ABCB9
位点：RS4275659
FAM234A
位点：RS9940149
BPTF
位点：RS12602912
MLX
位点：RS665268
ZZEF1
位点：RS7224685
GLP2R
位点：RS78761021
ZHX3
位点：RS17265513
PTGFRN
位点：RS1127655
PTH1R
位点：RS11926707
MBNL1
位点：RS4472028
SCD5
位点：RS993380
YTHDC2
位点：RS10077431
CTTNBP2
位点：RS13239186
RELN
位点：RS2299383
ZNF34
位点：RS2294120
USP3
位点：RS982077
EYA2
位点：RS6066138
SAMM50
位点：RS4823182
GRB14
位点：RS75536691
PSMD6
位点：RS3816157
MIR548AC
位点：RS1496653
FSCN3
位点：RS806215
PAX4
位点：RS2233580
ETS1
位点：RS11819995
GP2
位点：RS117267808
NFATC2
位点：RS6021276
Replication of the association between variants in the WFS1 gene and risk of type 2 diabetes in European populations
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Association of TCF7L2 Gene Polymorphisms with T2DM in the Population of Hyderabad, India
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Association between SLC30A8 rs13266634 Polymorphism and Type 2 Diabetes Risk: A Meta-Analysis
Replication of Genome-Wide Association Studies of Type 2 Diabetes Susceptibility in Japan - See more at: http://press.endocrine.org/doi/10.1210/jc.2008-0452?url_ver=Z39.88-2003&rfr_id=ori%3Arid%3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&#sthash.tkccZ0hT.dpuf
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
A polymorphism in the glucokinase gene that raises plasma fasting glucose, rs1799884, is associated with diabetes mellitus and prostate cancer: findings from a population-based, case-control study (the ProtecT study)
PPAR-γ2 and PTPRD gene polymorphisms influence type 2 diabetes patients' response to pioglitazone in China
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Variants in KCNQ1 are associated with susceptibility to type 2 diabetes mellitus
A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
The TRIB3 Q84R Polymorphism and Risk of Early-Onset Type 2 Diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
A form of the metabolic syndrome associated with mutations in DYRK1B.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan
A common functional exon polymorphism in the microsomal triglyceride transfer protein gene is associated with type 2 diabetes, impaired glucose metabolism and insulin levels
A Genome-Wide Association Study Identifies Susceptibility Variants for Type 2 Diabetes in Han Chinese
Replication of genome-wide association studies of type 2 diabetes susceptibility in Japan
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Confirmation of Multiple Risk Loci and Genetic Impacts by a Genome-Wide Association Study of Type 2 Diabetes in the Japanese Population
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication of KCNJ11 (p.E23K) and ABCC8 (p.S1369A) Association in Russian Diabetes Mellitus 2 Type Cohort and Meta-Analysis
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Replication Study of Candidate Genes Associated With Type 2 Diabetes Based On Genome-Wide Screening
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Progress in defining the genetic contribution to type 2 diabetes susceptibility.
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Genome-wide association analyses identify 143 risk variants and putative regulatory mechanisms for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Genome-wide association studies in the Japanese population identify seven novel loci for type 2 diabetes
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
Transferability of Type 2 Diabetes Implicated Loci in Multi-Ethnic Cohorts from Southeast Asia
Identification of 28 new susceptibility loci for type 2 diabetes in the Japanese population
深圳市市场监督管理局企业主体身份公示
中文
English